Efficacy and Safety of Acupuncture Treatment as an Adjunctive Therapy After Knee Replacement

July 7, 2021 updated by: Yun-Kyung Song, Gachon University Gil Oriental Medical Hospital

Efficacy and Safety of Acupuncture Treatment as an Adjunctive Therapy After Knee Replacement - Single-center, Pragmatic, Randomized, Assessor Blinded, Pilot Study-

Efficacy and Safety of Acupuncture Treatment as an Adjunctive Therapy After Knee Replacement

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Incheon, Korea, Republic of, 22711
        • Catholic Kwandong University International St. Mary's Hospital
      • Incheon, Korea, Republic of, 22761
        • Catholic Kwandong University International St. Mary'S Hospita

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Subject has a diagnosis of osteoarthritis and listed for an unilateral total knee replacement.
  • Subject has a normal cognitive function
  • Subject is willing and able to give informed consent for participation in the study.

Exclusion Criteria:

  • Those who have undergone total knee arthroplasty due to gout
  • Those who have had total knee arthroplasty due to trauma
  • Those who have had total knee arthroplasty due to autoimmune related diseases such as rheumatoid arthritis
  • Those who are participating in other clinical trials
  • Those who have a history of participating in other clinical trials within one month
  • Those who are difficult to write a research consent form
  • Those who are judged to be inappropriate for the clinical study by the researchers.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Acupuncture + Usual care
Acupuncture with Cnoxane Injection 40mg, Esomezol Capsule, Synerjet Semi Tablet and Ocoron Tablet
patients after surgery receive usual care(Cnoxane Injection 40mg, Esomezol Capsule, Synerjet Semi Tablet and Ocoron Tablet) as well as acupuncture treatment as an adjunctive therapy
Active Comparator: Usual care
Cnoxane Injection 40mg, Esomezol Capsule, Synerjet Semi Tablet and Ocoron Tablet
patients after surgery receive usual care alone(Cnoxane Injection 40mg, Esomezol Capsule, Synerjet Semi Tablet and Ocoron Tablet)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline in Korean version of Western Ontario and McMaster Universities Arthritis Index
Time Frame: Screening, day 11, day 21
K-WOMAC is widely used in the evaluation of Hip and Knee Osteoarthritis. It is a self-administered questionnaire consisting of 24 items divided into 3 subscales
Screening, day 11, day 21

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline in Numeric rating scale
Time Frame: Screening, baseline, day 5, 11, 21, 28, 84
NRS range was 0-10 with 0 being no pain and 10 the worst pain possible.
Screening, baseline, day 5, 11, 21, 28, 84
Change from baseline in Physical Condition related with mobility at every visit
Time Frame: Screening, day 11, day 84
mobility (5 meters walking test at comfortable speed - 5mWT) (meters/second)
Screening, day 11, day 84
Change from baseline in Physical Condition related with endurance at every visit
Time Frame: Screening, day 11, day 84
endurance (Sit-to-stand test - STS) (seconds)
Screening, day 11, day 84
Change from baseline in Timed Up and Go Test at every visit
Time Frame: Screening, day 11, day 84
a functional test evaluating the time to rise from a chair, walk 3 meters, turn around, walk back to the chair and sit down (abnormal cut-off value >12 seconds).
Screening, day 11, day 84
Change from baseline in Alternative-Step Test at every visit
Time Frame: Screening, day 11, day 84
a functional test measuring clinical balance performance, and it has been shown to predict fall risk among elderly subjects (seconds)
Screening, day 11, day 84
Change from baseline in Range of motion
Time Frame: Screening, baseline, day 5, 11, 28, 84
Compare flexion and extension angle using long arm goniometer between experimental and comparator group
Screening, baseline, day 5, 11, 28, 84

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 30, 2018

Primary Completion (Actual)

December 30, 2020

Study Completion (Actual)

May 30, 2021

Study Registration Dates

First Submitted

July 31, 2018

First Submitted That Met QC Criteria

August 13, 2018

First Posted (Actual)

August 16, 2018

Study Record Updates

Last Update Posted (Actual)

July 8, 2021

Last Update Submitted That Met QC Criteria

July 7, 2021

Last Verified

July 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • ISEE_2018_TKA_A

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Replacement

Clinical Trials on Acupuncture and Usual care

Subscribe